Back
Day Range
$64.88
$66.87
52-Week Range
$35.95
$87.50
Volume
671,291
50D / 200D Avg
$70.95
/
$63.75
Prev Close
$64.54
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 8.1 | 0.2 |
| P/B | — | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | 39.4 | 3.8 |
| Rev Growth 5Y % | 33.9 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$84.50
+26.6%
Low: $50.00
High: $120.00
Forward EPS
-$0.69
Est. Revenue
961.69M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.88
$3.53 – $6.30
|
1.67B | 2 |
| FY2029 |
$4.12
$2.98 – $5.32
|
1.56B | 4 |
| FY2028 |
$1.47
-$3.92 – $8.37
|
1.35B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | $0.10 | -$1.67 | -1718.2% |
| 2025-11-04 | -$1.19 | $0.20 | +116.8% |
| 2025-08-07 | -$1.07 | -$0.83 | +22.4% |
| 2025-05-06 | -$1.08 | $10.04 | +1029.6% |
| 2025-02-27 | -$1.12 | -$0.24 | +78.6% |
| 2024-11-07 | -$1.54 | -$1.39 | +9.7% |
| 2024-08-08 | -$1.00 | -$1.16 | -16.0% |
| 2024-04-25 | -$1.21 | -$1.20 | +0.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 33.89% annually over 5 years — strong growth
Net margin of 39.44% shows strong profitability
Generating 702.34M in free cash flow
P/E of 8.09 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 80.62%
Cash machine — converts 102.88% of earnings into free cash flow
Growth
Revenue Growth (5Y)
33.89%
Revenue (1Y)114.51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC223.85%
Net Margin39.44%
Op. Margin49.49%
Safety
Debt / Equity
N/A
Current Ratio2.35
Interest Coverage5.63
Valuation
P/E Ratio
8.09
Forward P/EN/A
P/B RatioN/A
EV/EBITDA5.88
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 114.51% | Revenue Growth (3Y) | 35.85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.73B | Net Income (TTM) | 682.64M |
| ROE | N/A | ROA | 23.45% |
| Gross Margin | 95.85% | Operating Margin | 49.49% |
| Net Margin | 39.44% | Free Cash Flow (TTM) | 702.34M |
| ROIC | 223.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.35 |
| Interest Coverage | 5.63 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 8.09 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 3.19 |
| PEG Ratio | -0.03 | Forward PEG | N/A |
| EV/EBITDA | 5.88 | Fwd EV/EBITDA | N/A |
| Forward P/S | 5.75 | Fwd Earnings Yield | N/A |
| FCF Yield | 12.71% | ||
| Market Cap | 5.53B | Enterprise Value | 5.03B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.73B | 806.78M | 937.82M | 698.80M | 538.59M |
| Net Income | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M |
| EPS (Diluted) | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 |
| Gross Profit | 1.66B | 749.38M | 872.34M | 654.12M | 506.27M |
| Operating Income | 856.51M | -302.57M | -439.50M | -447.41M | -374.44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.91B | 1.71B | 1.90B | 1.71B | 1.94B |
| Total Liabilities | 3.12B | 2.80B | 2.71B | 2.05B | 1.94B |
| Shareholders' Equity | -205.31M | -1.10B | -818.56M | -347.09M | 1.44M |
| Total Debt | 492.28M | 2.47B | 2.23B | 1.46B | 1.27B |
| Cash & Equivalents | 984.65M | 779.71M | 594.00M | 279.83M | 189.72M |
| Current Assets | 2.27B | 1.37B | 1.22B | 693.79M | 954.37M |
| Current Liabilities | 968.43M | 580.98M | 603.10M | 406.24M | 509.35M |